HS
DCPH

HighVista Strategies’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

HighVista Strategies’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,534
Closed -$658K – 146
2020
Q4 		$658K Buy
11,534
+951
+9% +$56.4K 0.42% 58
2020
Q3 		$543K Buy
10,583
+2,866
+37% +$140K 0.4% 41
2020
Q2 		$461K Buy
+7,717
New +$413K 0.38% 30

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HighVista Strategies's DCPH Position: Q1 2021 in Review

HighVista Strategies sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2021, closing a stake of 11,534 shares — an estimated $658K sold.

HighVista Strategies first reported a position in DCPH in Q2 2020 and held it in 3 quarters. The position peaked at $658K in Q4 2020. 167 funds tracked by Wall St. Rank hold DCPH as of Q1 2021.

  • HighVista Strategies reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • HighVista Strategies sold 11,534 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $658K.
  • HighVista Strategies first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • HighVista Strategies's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $658K in Q4 2020.
  • 167 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on HighVista Strategies's 13F filing for Q1 2021, filed 17 May 2021.